down arrow

Rezolute, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76200L3096
USD
9.70
0.81 (9.11%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

9.289.85

52 Week

2.2111.44
Valuation
Technical
Day's Volume

CASH

2.36 M

Shareholding (Mar 2025)

FII

8.03%

Held by 30 FIIs

DII

56.64%

Held by 37 DIIs

Promoter

3.60%

How big is Rezolute, Inc.?

22-Jun-2025

As of Jun 24, Rezolute, Inc. has a market capitalization of 353.19 million, with net sales of 0.00 million and a net profit of -73.00 million over the last four quarters. The company has shareholder's funds of 121.00 million and total assets of 132.74 million.

As of Jun 18, Rezolute, Inc. has a market capitalization of 353.19 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 24, the company reported net sales of 0.00 million for the latest four quarters, while the consolidated net profit for the same period was -73.00 million.<BR><BR>As of Jun 24, the balance sheet shows shareholder's funds of 121.00 million and total assets of 132.74 million.

Read More

What does Rezolute, Inc. do?

22-Jun-2025

Rezolute, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology sector, currently reporting a net profit loss of $19 million and a market cap of $353.19 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -87.28%.

Overview:<BR>Rezolute, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: -19 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 353.19 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.04 <BR>Return on Equity: -87.28% <BR>Price to Book: 4.28<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Rezolute, Inc. technically bullish or bearish?

20-Sep-2025

As of July 24, 2025, Rezolute, Inc. exhibits a strong bullish trend supported by positive MACD and Bollinger Bands indicators, despite a mildly bearish KST signal, and has significantly outperformed the S&P 500 with a year-to-date return of 67.35%.

As of 24 July 2025, the technical trend for Rezolute, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate bullishness across both periods. The daily moving averages are bullish, further reinforcing the positive trend. However, the KST shows a mildly bearish signal on the monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames.<BR><BR>In terms of performance, Rezolute has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 67.35% compared to the S&P 500's 12.22%, and a one-year return of 68.38% versus 17.14%. Overall, the technical indicators suggest a strong bullish sentiment for Rezolute, Inc.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 692 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.04

stock-summary
Return on Equity

-87.28%

stock-summary
Price to Book

8.38

Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-19 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
33.98%
0%
33.98%
6 Months
119.46%
0%
119.46%
1 Year
81.31%
0%
81.31%
2 Years
1102.58%
0%
1102.58%
3 Years
444.94%
0%
444.94%
4 Years
130.4%
0%
130.4%
5 Years
-53.79%
0%
-53.79%

Rezolute, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Rezolute, Inc. technically bullish or bearish?

As of 24 July 2025, the technical trend for Rezolute, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly time frames, and Bollinger Bands also indicate bullishness across both periods. The daily moving averages are bullish, further reinforcing the positive trend. However, the KST shows a mildly bearish signal on the monthly, and Dow Theory indicates a mildly bullish stance on both weekly and monthly time frames. In terms of performance, Rezolute has significantly outperformed the S&P 500 across multiple periods, with a year-to-date return of 67.35% compared to the S&P 500's 12.22%, and a one-year return of 68.38% versus 17.14%. Overall, the technical indicators suggest a strong bullish sentiment for Rezolute, Inc....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-212.93%
EBIT to Interest (avg)
-48.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.04
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
92.10%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.59
EV to EBIT
-3.79
EV to EBITDA
-3.79
EV to Capital Employed
-78.90
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-87.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 11 Schemes (31.73%)

Foreign Institutions

Held by 30 Foreign Institutions (8.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -10.53% vs -8.92% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-20.00",
          "val2": "-16.20",
          "chgp": "-23.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-2.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-18.90",
          "val2": "-17.10",
          "chgp": "-10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2024 is -32.24% vs -26.03% in Jun 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-70.40",
          "val2": "-55.60",
          "chgp": "-26.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.90",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-68.50",
          "val2": "-51.80",
          "chgp": "-32.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoYstock-summary
Mar'25
Mar'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-20.00
-16.20
-23.46%
Interest
0.00
0.00
Exceptional Items
-0.00
-2.00
100.00%
Consolidate Net Profit
-18.90
-17.10
-10.53%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is -10.53% vs -8.92% in Mar 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Jun'24stock-summary
Jun'24
Jun'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-70.40
-55.60
-26.62%
Interest
0.00
0.00
Exceptional Items
-2.90
-0.00
Consolidate Net Profit
-68.50
-51.80
-32.24%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Jun 2024 is 0.00% vs 0.00% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2024 is -32.24% vs -26.03% in Jun 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Rezolute, Inc. stock-summary
stock-summary
Rezolute, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."